Early to late phase drug manufacturing services for others; and manufacturing of drug substances and custom synthesis for new or transferred substances for others

Scientific, technological and testing services, namely, microbiological testing in the pharmaceutical and medical device industries; container closure integrity testing; bacterial filter integrity testing; mycoplasma testing; sterilization validation testing; cleaning validation testing; package validation testing; accelerated aging studies, namely, conducting technical research in the field of product aging; disinfectant qualification programs for clean rooms, namely, developing quality control standards for clean rooms; clean room testing and support services in the nature of monitoring clean room manufacturing practices for quality control operational and design purposes; clean room environmental monitoring services, namely, air surface monitoring, personnel monitoring in the nature of conducting surveys to determine if clean room employees meet employee clean room requirements and standards, temperature and humidity monitoring, pressure differential monitoring, incubation analysis and reporting and isolate characterization and identification; research and process services in the pharmaceutical industry; analytical testing and development services for the pharmaceutical industry, namely, structural determination and impurity identification; material characterization, namely, materials testing; evaluation of potential genotoxic impurities in the production of drugs; impurity isolation, namely, chemical laboratory services in the field of impurity isolation for the pharmaceutical industry; analysis of raw materials to specifications; analytical testing to monitor the synthesis and release of drugs; bioanalytical analysis to support discovery and preclinical drug metabolism studies; conducting stability studies of pharmaceutical products; and research and development of drug formulations